Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A phenome-wide association and Mendelian randomisation study of alcohol use variants in a diverse cohort comprising over 3 million individuals

  • Jennings, Mariela V.
  • Martínez-Magaña, José Jaime
  • Courchesne-Krak, Natasia S.
  • Cupertino , Renata B.
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Bianchi, Sevim B.
  • Hatoum, Alexander S.
  • Atkinson, Elizabeth G.
  • Giusti-Rodriguez, Paola
  • Montalvo-Ortiz, Janitza L.|||0000-0002-7657-8365
  • Gelernter, Joel|||0000-0002-4067-1859
  • Soler Artigas, María|||0000-0002-3213-1107
  • Elson, Sarah L.
  • Edenberg, Howard J.|||0000-0003-0344-9690
  • Fontanillas, Pierre
  • Palmer, Abraham A.
  • Sánchez Roige, Sandra|||0000-0001-6137-5699
Alcohol consumption is associated with numerous negative social and health outcomes. These associations may be direct consequences of drinking, or they may reflect common genetic factors that influence both alcohol consumption and other outcomes. We performed exploratory phenome-wide association studies (PheWAS) of three of the best studied protective single nucleotide polymorphisms (SNPs) in genes encoding ethanol metabolising enzymes (ADH1B : rs1229984-T, rs2066702-A; ADH1C : rs698-T) using up to 1109 health outcomes across 28 phenotypic categories (e.g., substance-use, mental health, sleep, immune, cardiovascular, metabolic) from a diverse 23andMe cohort, including European (N ≤ 2,619,939), Latin American (N ≤ 446,646) and African American (N ≤ 146,776) populations to uncover new and perhaps unexpected associations. These SNPs have been consistently implicated by both candidate gene studies and genome-wide association studies of alcohol-related behaviours but have not been investigated in detail for other relevant phenotypes in a hypothesis-free approach in such a large cohort of multiple ancestries. To provide insight into potential causal effects of alcohol consumption on the outcomes significant in the PheWAS, we performed univariable two-sample and one-sample Mendelian randomisation (MR) analyses. The minor allele rs1229984-T, which is protective against alcohol behaviours, showed the highest number of PheWAS associations across the three cohorts (N = 232, European; N = 29, Latin American; N = 7, African American). rs1229984-T influenced multiple domains of health. We replicated associations with alcohol-related behaviours, mental and sleep conditions, and cardio-metabolic health. We also found associations with understudied traits related to neurological (migraines, epilepsy), immune (allergies), musculoskeletal (fibromyalgia), and reproductive health (preeclampsia). MR analyses identified evidence of causal effects of alcohol consumption on liability for 35 of these outcomes in the European cohort. Our work demonstrates that polymorphisms in genes encoding alcohol metabolising enzymes affect multiple domains of health beyond alcohol-related behaviours. Understanding the underlying mechanisms of these effects could have implications for treatments and preventative medicine. MVJ, NCK, SBB, SSR and AAP were supported by T32IR5226 and 28IR-0070. SSR was also supported by DP1DA054394. NCK and RBC were also supported by R25MH081482. ASH was supported by funds from NIAAA K01AA030083. JLMO was supported by VA 1IK2CX002095. JLMO and JJMM were also supported by R21DA050160. JJMM was also supported by the for Academic Diversity. EGA was supported by K01MH121659 from the /, the and the at . MSA was supported by the and co-funded by the : (FSE+) (P19/01224, PI22/00464 and CP22/00128).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Associations between air pollution and surrounding greenness with internalizing and externalizing behaviors among schoolchildren

  • Zubizarreta-Arruti, Uxue
  • Bosch, Rosa|||0000-0002-7596-183X
  • Soler Artigas, María|||0000-0002-3213-1107
  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Llonga, Natalia|||0000-0003-4325-6201
  • Carabí-Gassol, Pau
  • Macias-Chimborazo, Valeria
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Prat, Raquel|||0000-0001-8097-6617
  • Rivas, Cristina|||0000-0002-8074-9550
  • Pagespetit, Èlia
  • Puigbó, Júlia
  • Español-Martín, Gemma|||0000-0002-2362-8189
  • Raimbault, B.|||0000-0003-0226-0220
  • Valentín, Antònia|||0000-0002-9275-7101
  • Sunyer Deu, Jordi|||0000-0002-2602-4110
  • Foraster, Maria|||0000-0003-4450-4123
  • Gascon, Mireia|||0000-0003-4537-8472
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
Air pollution and greenness are emerging as modifiable risk and protective factors, respectively, in child psychopathology. However, research shows inconsistencies. Here, we examined associations between air pollution and surrounding greenness with internalizing and externalizing behaviors. In addition, the potential modifying role of the genetic susceptibility for these traits and socioeconomic status (SES) was explored. This population-based study included 4485 schoolchildren aged 5-18 years from Spain. Internalizing and externalizing behaviors were assessed using the Child Behavior Checklist (CBCL). Average air pollution (NO, PM, PM, PM, and PM absorbance) and surrounding greenness (NDVI within 100-m, 300-m, and 500-m buffers) school exposure were estimated for 12 months before outcome assessment. Genetic liability was assessed by computing polygenic risk scores (PRS) and SES was calculated using the Hollingshead Four-Factor Index. Associations were analyzed using negative binomial mixed-effects models. Although no associations survived multiple testing, we found that increases of 5.48 μg/m 3 in PM and 2.93 μg/m 3 in PM were associated with a 6% (Mean Ratio (MR) = 1.06; 95% CI: 1.01-1.12) and a 4% (MR = 1.04; 95% CI: 1.00-1.09) increase in internalizing behavior scores. A 0.1 increase in NDVI within a 100-m buffer was associated with a 6% decrease in externalizing behavior (MR = 0.94; 95% CI: 0.89-0.99). Neither differences by sex or age, or moderation effects by PRS or SES, were observed. We found preliminary evidence of detrimental effects of air pollution on internalizing behavior and protective effects of greenness on externalizing behavior, which were not modified by sex, age, SES, or genetic liability. If confirmed, these results reinforce the need for improving air quality, especially around schools, as part of preventive strategies focused on childhood psychopathology.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Common and rare variant contributions to discontinuation of stimulant treatment in ADHD

  • Thirstrup, Janne Pia
  • Duan, Jinjie
  • Albiñana, Clara
  • Dalsgaard, Søren
  • Ribases, Marta
  • Soler Artigas, María
Attention-deficit hyperactivity disorder; Personalized medicine; Pharmacogenomics, Trastorn per dèficit d'atenció amb hiperactivitat; Medicina personalitzada; Farmacogenòmica, Trastorno por déficit de atención con hiperactividad; Medicina personalizada; Farmacogenómica, Stimulants are the first-line pharmacological treatment for ADHD and generally effective, yet 35–61% of individuals discontinue treatment within a year. We investigated the contribution of common and rare genetic variants to early stimulant discontinuation using data from 18,362 individuals with ADHD (31% female) initiating stimulants in iPSYCH, a Danish population-based case-cohort linked to national registers. Discontinuation was defined as a ≥ 180-day gap between dispensations within one year of initiation. We examined genetic differences by age groups, estimated SNP-heritability (h2SNP), conducted genome-wide association studies (GWAS), polygenic score (PGS) analyses, and assessed associations with protein truncating variants (PTV). Within one year, 7102 individuals (39%) had discontinued stimulants. Age-stratified analyses (cut-off: age 16) revealed low genetic correlation (r₉ = 0.23, 95% CI: –0.37, 0.83) between children and adolescents/adults. The h²snp for discontinuation was 0.06 (95% CI: 0.02, 0.11) overall, 0.08 (95% CI: 0.02, 0.14) in children, and 0.14 (95% CI: 0.02, 0.27) in adolescents/adults. No genome-wide significant loci were identified overall or in adolescents/adults; however, one locus (SLC5A12, chromosome 11) reached genome-wide significance in children. Ten of 36 PGSs were associated with discontinuation, with higher psychiatric risk PGSs predicting increased discontinuation, while educational attainment and BMI PGSs showed divergent effects by age. Reduced burden of dopamine-related PTVs was nominally associated with discontinuation, particularly in adolescents/adults. These findings suggest modest contributions of both common and rare variants to stimulant discontinuation in ADHD and point to potential developmental differences in genetic architecture., This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 965381 (TIMESPAN). This research reflects only the authors’ view, and the European Commission is not responsible for any use that may be made of the information it contains. Ditte Demontis was supported by the Novo Nordisk Foundation (NNF20OC0065561, NNF21SA0072102, NNF23OC0083657), the Lundbeck Foundation (R344-2020-1060). The iPSYCH team was supported by grants from the ISCIII Lundbeck Foundation (R102-A9118, R155-2014-1724, and co-funded R248-2017-2003), NIH/NIMH (1R01MH124851-01 to Anders D. Børglum), and the Universities and University Hospitals of Aarhus and Copenhagen. The Danish National Biobank resource was supported by the Novo Nordisk Foundation. High-performance computer capacity for handling and statistical analysis of iPSYCH data on the GenomeDK HPC facility was provided by the Center for Genomics and Personalized Medicine and the Centre for Integrative Sequencing, iSEQ, Aarhus University, Denmark (grant to Anders D. Børglum). Søren Dalsgaard was supported by Sawmill-owner Jeppe Juhl’s and wife Ovita Juhl’s Fund, The Capital Region (grant No 22042850), and Greater Copenhagen Health Science Partners (CAG Precision Psychiatry, A7763). Marta Soler Artigas acknowledges a Miguel Servet contract (CP22/00128) awarded by the Instituto de Salud Carlos III and co-funded by the European Union Found: Fondo Social Europeo Plus, FSE + . We acknowledge The Swedish Twin Registry for access to data. The Swedish Twin Registry is managed by Karolinska Institutet and receives funding through the Swedish Research Council under the grant no 2021-00180.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Bosch, Rosa
  • Carabí-Gassol, Pau
  • MACÍAS CHIMBORAZO, VALERIA
  • Español Martin, Gemma
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Attention-deficit/hyperactivity disorder; Autism spectrum disorder; School performance, Trastorn per dèficit d'atenció i hiperactivitat; Trastorn de l'espectre autista; Rendiment escolar, Trastorno por déficit de atención e hiperactividad; Trastorno del espectro autista; Rendimiento escolar, Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404, PI23/00026 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Network Center for Biomedical Research (CIBER) to J.C.D.; the European Regional Development Fund (ERDF); the ECNP Network ‘ADHD across the Lifespan’; “la Marató de TV3” (202228-30 and 202228-31), “Fundació ‘la Caixa’, Diputació de Barcelona, Pla Estratègic de Recerca i Innovació en Salut” (PERISSLT006/17/285); “Fundació Privada d’Investigació Sant Pau” (FISP); and Ministry of Health of Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genetic architecture of ADHD and overlap with other psychiatric disorders and cognition-related phenotypes

  • hartman, catharina
  • Larsson, Henrik
  • Ribases, Marta
  • Mitjans, Marina
  • Soler Artigas, María
  • Demontis, Ditte
  • Ramos-Quiroga, Josep Antoni
Trastorno por déficit de atención e hiperactividad; Comorbilidad; Genética de trastornos cruzados, Trastorn per dèficit d'atenció i hiperactivitat; Comorbiditat; Genètica de trastorns creuats, Attention-deficit/hyperactivity disorder; Comorbidity; Cross-disorder genetics, Attention-deficit/hyperactivity disorder (ADHD) co-occurs with many other psychiatric disorders and traits. In this review, we summarize and interpret the existing literature on the genetic architecture of these comorbidities based on hypothesis-generating approaches. Quantitative genetic studies indicate that genetic factors play a substantial role in the observed co-occurrence of ADHD with many different disorders and traits. Molecular genetic correlations derived from genome-wide association studies and results of studies based on polygenic risk scores confirm the general pattern but provide effect estimates that are smaller than those from twin studies. The identification of the specific genetic variants and biological pathways underlying co-occurrence using genome-wide approaches is still in its infancy. The first analyses of causal inference using genetic data support causal relationships between ADHD and comorbid disorders, although bidirectional effects identified in some instances point to complex relationships. While several issues in the methodology and inferences from the results are still to be overcome, this review shows that the co-occurrence of ADHD with many psychiatric disorders and traits is genetically interpretable., This research has received funding from the EU’s Horizon 2020 research and innovation program under grant agreements no. 667302 (CoCA), 728018 (Eat2beNICE) and 2020604 (TIMESPAN) and from the ECNP Network ‘ADHD across the Lifespan' (https://www.ecnp.eu/researchinnovation/ECNP-networks/List-ECNP-Networks/). B Cormand has also been supported by the Spanish Ministerio de Ciencia, Innovación y Universidades (PID2021-1277760B-I100), the Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas (PNSD-2017I050), Fundació La Marató de TV3 (202218-31), Generalitat de Catalunya/AGAUR (2021-SGR-1093), ICREA Academia 2021 and the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 841899 (GRASAD) and 101028810 (ATTENTIVE). M Ribasés was also supported by the European Union H2020 Programme (H2020/2014–2020) under grant agreement no. 848228 (DISCOvERIE), by the Instituto de Salud Carlos III (PI20/00041, CP09/00119 and CPII15/00023), by the Pla estratègic de recerca i innovació en salut (PERIS), Generalitat de Catalunya (METAL-Cat; SLT006/17/287), by the Agència de Gestió d'Ajuts Universitaris i de Recerca AGAUR, Generalitat de Catalunya (2017SGR1461) and by Fundació La Marató de TV3 (202228-30, 202228-31). JA Ramos-Quiroga was also supported by the European Union H2020 Programme (H2020/2014–2020) under grant agreement no. 848228 (DISCOvERIE). M Mitjans was supported by Horizon 2020 Marie Sklodowska-Curie Individual Fellowship from the European Commission under grant agreement no. 841899 (GRASAD), the MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU”/PRTR” (RYC2021-033573-I), Ministerio de Ciencia e Innovación (PID2022-139740OA-100) and the Agència de Gestió d'Ajuts Universitaris i de Recerca AGAUR, Generalitat de Catalunya (2021-SGR-1093). M Soler Artigas was supported by the Instituto de Salud Carlos III (P19/01224, PI22/00464 and CP22/00128) and by the European Regional Development Fund. B Franke and A Reif were also supported by funding from the EU’s Horizon 2020 research and innovation program under grant agreement no. 847879 (PRIME). B Franke also received relevant funding from the Netherlands Organization for Scientific Research (NWO) for the GUTS project (grant 024.005.011). D Demontis is supported by the Novo Nordisk Foundation (NNF20OC0065561 and NNF21SA0072102), the Lundbeck Foundation (R344-2020-1060), the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 965381 (TIMESPAN). AD Børglum was supported by the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003). Research reported in this publication was also supported by the National Institute of Mental Health of the National Institutes of Health under Award Number R01MH124851. The content of the publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or any of the other funding organisations mentioned here.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Arribas, Lorena
  • Demontis, Ditte
  • Cabana-Dominguez, Judit
  • Llonga, Natalia
  • Alemany, Silvia
  • Vilar-Ribo, Laura
  • Fadeuilhe, Christian
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Soler Artigas, María
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Transcriptomic risk scores; Attention deficit and hyperactivity disorder, Puntuaciones de riesgo transcriptómico; Trastorno por déficit de atención e hiperactividad, Puntuació de risc transcriptòmic; Trastorn per dèficit d'atenció i hiperactivitat, Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III and co-funded by the European Union Found: Fondo Social Europeo Plus (FSE+) (P19/01224, PI20/00041, PI22/00464 and FI18/00285 to LVR, CP22/00128 to MSA and CP22/00026 to SA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD), the Network Center for Biomedical Research (CIBER) to JCD, the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’ and the “la Marató de TV3” (202228-30 and 202228-31). ADB was supported by grants from the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003) and NIH/NIMH (1R01MH124851-01). DD was supported by the Novo Nordisk Foundation (NNF20OC0065561) and the Lundbeck Foundation (R344-2020-1060).
Dipòsit Digital de Documents de la UAB
Publicación Artículo preliminar (WorkingPaper)

Genome-wide association study identifies 30 obsessive-compulsive disorder associated loci

  • Strom, Nora I.|||0000-0002-5261-8852
  • Gerring, Zachary F.|||0000-0002-2445-1266
  • Galimberti, Marco|||0000-0001-6052-156X
  • Yu, Dongmei|||0000-0001-7901-4365
  • Halvorsen, Matthew W.|||0000-0002-6707-2418
  • Abdellaoui, Abdel|||0000-0003-1088-6784
  • Rodriguez-Fontenla, Cristina|||0000-0002-9829-6393
  • Sealock, Julia M.|||0000-0002-9346-3498
  • Bigdeli, Tim B.|||0000-0003-2215-5946
  • Coleman, Jonathan R. I.|||0000-0002-6759-0944
  • Mahjani, Behrang|||0000-0001-6087-9537
  • Thorp, Jackson G.|||0000-0002-9461-6417
  • Bey, Katharina|||0000-0001-6392-4997
  • Burton, Christie L.|||0000-0002-8955-6528
  • Luykx, Jurjen J.|||0000-0002-6439-2774
  • Zai, Gwyneth|||0000-0002-0894-6867
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Andre, Christine
  • Askland, Kathleen D.|||0000-0003-1467-8923
  • Banaj, Nerisa|||0000-0002-6317-8549
  • Barlassina, Cristina|||0000-0001-7407-2697
  • Nissen, Judith Becker|||0000-0003-4063-6866
  • Bienvenu, O. Joseph|||0000-0002-8466-102X
  • Black, Donald|||0000-0001-8038-1971
  • Bloch, Michael H.|||0000-0003-0352-4080
  • Boberg, Julia|||0000-0003-3399-2838
  • Børte, Sigrid|||0000-0001-9540-3256
  • Bosch, Rosa|||0000-0002-7596-183X
  • Breen, Michael
  • Brennan, Brian P.|||0000-0001-5468-6552
  • Brentani, Helena|||0000-0001-5192-4682
  • Buxbaum, Joseph D.|||0000-0001-8898-8313
  • Bybjerg-Grauholm, Jonas|||0000-0003-1705-4008
  • Byrne, Enda M.|||0000-0002-9491-7797
  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Camarena, Beatriz
  • Camarena, Adrian|||0000-0001-8512-0607
  • Cappi, Carolina|||0000-0001-6661-3756
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Cavallini, Maria Cristina|||0000-0001-5913-1468
  • Ciullo, Valentina|||0000-0002-4095-7806
  • Cook, Edwin H.|||0000-0002-5848-5114
  • Crosby, Jesse
  • Cullen, Bernadette A.|||0000-0003-1762-092X
  • De Schipper, Elles J.|||0000-0001-9494-451X
  • Delorme, Richard|||0000-0002-5614-3663
  • Djurovic, Srdjan|||0000-0002-8140-8061
  • Elias, Jason A.
  • Estivill, Xavier|||0000-0002-0723-2256
  • Falkenstein, Martha J.|||0000-0001-5074-3409
  • Fundin, Bengt T.|||0000-0002-6037-7331
  • Garner, Lauryn
  • German, Chris
  • Gironda, Christina
  • Goes, Fernando S.|||0000-0001-6262-8264
  • Grados, Marco A.|||0000-0002-0178-1764
  • Grove, Jakob|||0000-0003-2284-5744
  • Guo, Wei|||0000-0002-4322-3699
  • Haavik, Jan|||0000-0001-7865-2808
  • Hagen, Kristen|||0000-0002-4286-1277
  • Harrington, Kelly|||0000-0001-9668-183X
  • Havdahl, Alexandra|||0000-0002-9268-0423
  • Höffler, Kira D.|||0000-0002-0837-1469
  • Hounie, Ana G.|||0000-0002-5026-2880
  • Hucks, Donald|||0000-0002-2700-5798
  • Hultman, Christina|||0000-0002-0327-2410
  • Janecka, Magdalena|||0000-0001-7406-0776
  • Jenike, Eric
  • Karlsson, Elinor K.|||0000-0002-4343-3776
  • Kelley, Kara
  • Klawohn, Julia|||0000-0002-9436-6948
  • Krasnow, Janice E.|||0000-0003-0316-6279
  • Krebs, Kristi|||0000-0003-0494-2751
  • Lange, Christoph|||0000-0002-9691-4741
  • Lanzagorta, Nuria|||0000-0001-6769-6813
  • Levey, Daniel|||0000-0001-8431-9569
  • Lindblad-Toh, Kerstin|||0000-0001-8338-0253
  • Macciardi, Fabio|||0000-0003-0537-4266
  • Maher, Brion|||0000-0001-9809-0064
  • Mathes, Brittany
  • McArthur, Evonne|||0000-0003-4566-4321
  • McGregor, Nathaniel|||0000-0001-7195-4993
  • McLaughlin, Nicole C.|||0000-0002-4016-2747
  • Meier, Sandra|||0000-0002-3287-5894
  • Miguel, Euripedes C.|||0000-0002-9393-3103
  • Mulhern, Maureen|||0000-0001-8642-4741
  • Nestadt, Paul S.
  • Nurmi, Erika L.|||0000-0003-4893-8957
  • O'Connell, Kevin S.|||0000-0002-6865-8795
  • Osiecki, Lisa|||0000-0002-9408-8722
  • Ousdal, Olga Therese|||0000-0002-0728-3141
  • Palviainen, Teemu|||0000-0002-7847-8384
  • Pedersen, Nancy L.|||0000-0001-8057-3543
  • Piras, Fabrizio|||0000-0003-3566-5494
  • Piras, Federica|||0000-0002-9546-7038
  • Potluri, Sriramya|||0000-0003-3877-0038
  • Rabionet, Raquel|||0000-0001-5006-8140
  • Ramirez, Alfredo|||0000-0003-4991-763X
  • Rauch, Scott|||0000-0001-7699-6754
  • Reichenberg, Abraham|||0000-0003-2729-8575
  • Riddle, Mark A.|||0000-0001-8764-2134
  • Ripke, Stephan|||0000-0003-3622-835X
  • Rosário, Maria C.|||0000-0002-8577-3306
  • Sampaio, Aline S.|||0000-0001-5568-6167
  • Schiele, Miriam A.|||0000-0003-2613-6515
  • Skogholt, Anne Heidi|||0000-0001-7466-0405
  • Sloofman, Laura G Sloofman G.|||0000-0001-7628-4378
  • Smit, Jan
  • Soler Artigas, María|||0000-0002-3213-1107
  • Thomas, Laurent|||0000-0003-0548-2486
  • Tifft, Eric|||0000-0002-7480-0276
  • Vallada, Homero|||0000-0001-5123-8295
  • van Kirk, Nathanial|||0000-0002-1975-4238
  • Veenstra-VanderWeele, Jeremy|||0000-0002-6349-1076
  • Vulink, Nienke N.|||0000-0001-8991-9627
  • Walker, Christopher P.|||0000-0002-6069-0184
  • Wang, Ying
  • Wendland, Jens|||0000-0001-5106-5013
  • Winsvold, Bendik Slagsvold|||0000-0003-4171-8919
  • Yao, Yin|||0000-0001-7487-4294
  • Zhou, Hang|||0000-0002-7694-6391
  • Agrawal, Arpana|||0000-0002-0313-793X
  • Alonso, Pino|||0000-0002-5779-9111
  • Berberich, Götz|||0000-0001-8300-9294
  • Bucholz, Kathleen K.|||0000-0003-3794-0736
  • Bulik, Cynthia M.|||0000-0001-7772-3264
  • Cath, Danielle|||0000-0001-9539-4118
  • Denys, Damiaan|||0000-0002-3191-3844
  • Eapen, Valsamma|||0000-0001-6296-8306
  • Edenberg, Howard J.|||0000-0003-0344-9690
  • Falkai, Peter|||0000-0003-2873-8667
  • Fernandez, Thomas V.|||0000-0003-0830-022X
  • Fyer, Abby J.|||0000-0002-0944-2505
  • Gaziano, J M.|||0000-0002-5384-9767
  • Geller, Dan A.|||0000-0001-8692-4156
  • Grabe, Hans J.|||0000-0003-3684-4208
  • Greenberg, Benjamin D.|||0000-0002-5648-0002
  • Hanna, Gregory L.|||0000-0002-0742-6990
  • Hickie, Ian B.|||0000-0001-8832-9895
  • Hougaard, David M.|||0000-0001-5928-3517
  • Kathmann, Norbert|||0000-0002-1348-7060
  • Kennedy, James L.|||0000-0002-8733-3806
  • Lai, Dongbing|||0000-0001-7803-580X
  • Landén, Mikael|||0000-0002-4496-6451
  • Le Hellard, Stéphanie|||0000-0002-8085-051X
  • Leboyer, Marion|||0000-0001-5473-3697
  • Lochner, Christine|||0000-0002-4766-3704
  • McCracken, James T.|||0000-0003-0370-0777
  • Medland, Sarah Elizabeth|||0000-0003-1382-380X
  • Mortensen, Preben B.|||0000-0002-4782-1450
  • Neale, Benjamin M.|||0000-0003-1513-6077
  • Nicolini, Humberto|||0000-0003-2494-0067
  • Nordentoft, Merete|||0000-0003-4895-7023
  • Pato, Michele
  • Pato, Carlos|||0000-0002-5858-266X
  • Pauls, David L.|||0000-0002-8107-345X
  • Piacentini, John|||0000-0003-4195-7194
  • Pittenger, Christopher|||0000-0003-2117-9321
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Rasmussen, Steven A.|||0000-0002-8327-0692
  • Richter, Margaret A.|||0000-0001-5450-2936
  • Rosenberg, David R.|||0000-0002-0005-4151
  • Ruhrmann, Stephan|||0000-0002-6022-2364
  • Samuels, Jack F.|||0000-0002-6715-7905
  • Sandin, Sven|||0000-0001-6994-4884
  • Sandor, Paul|||0000-0003-2397-0758
  • Spalletta, Gianfranco|||0000-0002-7432-4249
  • Stein, Dan J.|||0000-0001-7218-7810
  • Stewart, S. Evelyn|||0000-0002-0994-6383
  • Storch, Eric A.|||0000-0002-7631-3703
  • Stranger, Barbara E.|||0000-0001-9021-7331
  • Turiel, Maurizio|||0000-0002-8793-2112
  • Werge, Thomas|||0000-0003-1829-0766
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Walitza, Susanne|||0000-0002-8161-8683
  • Hveem, Kristian|||0000-0001-8157-9744
  • Hansen, Bjarne K.|||0000-0001-5659-1119
  • Rück, Christian P.|||0000-0002-8742-0168
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • Milani, Lili|||0000-0002-5323-3102
  • Mors, Ole|||0000-0002-5660-0393
  • Reichborn-Kjennerud, Ted|||0000-0003-4653-0034
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Kvale, Gerd|||0000-0001-5449-2344
  • Mataix-Cols, David|||0000-0002-4545-0924
  • Domschke, Katharina|||0000-0002-2550-9132
  • Grünblatt, Edna|||0000-0001-8505-7265
  • Wagner, Michael
  • Zwart, John-Anker|||0000-0001-5721-0154
  • Breen, Gerome|||0000-0003-2053-1792
  • Nestadt, Gerald|||0000-0001-9461-5249
  • Kaprio, Jaakko|||0000-0002-3716-2455
  • Arnold, Paul D.|||0000-0003-2496-4624
  • Grice, Dorothy E.|||0000-0002-8833-2549
  • Knowles, James A.|||0000-0002-3307-5741
  • Ask, Helga|||0000-0003-0149-5319
  • Verweij, Karin|||0000-0001-9868-7821
  • Davis, Lea K.|||0000-0001-5143-2282
  • Smit, Dirk J.|||0000-0001-8301-8860
  • Crowley, James J.|||0000-0001-9051-1557
  • Scharf, Jeremiah M.|||0000-0002-4742-5896
  • Stein, Murray B.|||0000-0001-9564-2871
  • Gelernter, Joel|||0000-0002-4067-1859
  • Mathews, Carol A.|||0000-0003-2208-7058
  • Derks, Eske M.|||0000-0002-6292-6883
  • Mattheisen, Manuel|||0000-0002-8442-493X
Obsessive-compulsive disorder (OCD) affects ~1% of the population and exhibits a high SNP-heritability, yet previous genome-wide association studies (GWAS) have provided limited information on the genetic etiology and underlying biological mechanisms of the disorder. We conducted a GWAS meta-analysis combining 53,660 OCD cases and 2,044,417 controls from 28 European-ancestry cohorts revealing 30 independent genome-wide significant SNPs and a SNP-based heritability of 6.7%. Separate GWAS for clinical, biobank, comorbid, and self-report sub-groups found no evidence of sample ascertainment impacting our results. Functional and positional QTL gene-based approaches identified 249 significant candidate risk genes for OCD, of which 25 were identified as putatively causal, highlighting WDR6, DALRD3, CTNND1 and genes in the MHC region. Tissue and single-cell enrichment analyses highlighted hippocampal and cortical excitatory neurons, along with D1- and D2-type dopamine receptor-containing medium spiny neurons, as playing a role in OCD risk. OCD displayed significant genetic correlations with 65 out of 112 examined phenotypes. Notably, it showed positive genetic correlations with all included psychiatric phenotypes, in particular anxiety, depression, anorexia nervosa, and Tourette syndrome, and negative correlations with a subset of the included autoimmune disorders, educational attainment, and body mass index.. This study marks a significant step toward unraveling its genetic landscape and advances understanding of OCD genetics, providing a foundation for future interventions to address this debilitating disorder.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic architecture of ADHD and overlap with other psychiatric disorders and cognition-related phenotypes

  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Mitjans, M.
  • Hartman, CA.
  • Artigas, M. Soler
  • Demontis, Ditte|||0000-0001-9124-2766
  • Larsson, Henrik
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Kuntsi, J.
  • Faraone, Stephen V.|||0000-0002-9217-3982
  • Børglum, AD.
  • Reif, Andreas|||0000-0002-0992-634X
  • Franke, Barbara|||0000-0003-4375-6572
  • Cormand, Bru|||0000-0001-5318-4382
Attention-deficit/hyperactivity disorder (ADHD) co-occurs with many other psychiatric disorders and traits. In this review, we summarize and interpret the existing literature on the genetic architecture of these comorbidities based on hypothesis-generating approaches. Quantitative genetic studies indicate that genetic factors play a substantial role in the observed co-occurrence of ADHD with many different disorders and traits. Molecular genetic correlations derived from genome-wide association studies and results of studies based on polygenic risk scores confirm the general pattern but provide effect estimates that are smaller than those from twin studies. The identification of the specific genetic variants and biological pathways underlying co-occurrence using genome-wide approaches is still in its infancy. The first analyses of causal inference using genetic data support causal relationships between ADHD and comorbid disorders, although bidirectional effects identified in some instances point to complex relationships. While several issues in the methodology and inferences from the results are still to be overcome, this review shows that the co-occurrence of ADHD with many psychiatric disorders and traits is genetically interpretable.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Llonga, Natalia|||0000-0003-4325-6201
  • Arribas, Lorena|||0000-0002-9683-9999
  • Alemany Sierra, Silvia|||0000-0002-7925-6767
  • Vilar-Ribó, L.|||0000-0001-8758-523X
  • Demontis, Ditte|||0000-0001-9124-2766
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Soler Artigas, María|||0000-0002-3213-1107
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Common and rare variant contributions to discontinuation of stimulant treatment in ADHD

  • Thirstrup, Janne Pia
  • Duan, Jinjie
  • Albiñana, Clara
  • Dalsgaard, Søren
  • Ribases, Marta
  • Soler Artigas, María
Attention-deficit hyperactivity disorder; Personalized medicine; Pharmacogenomics, Trastorn per dèficit d'atenció amb hiperactivitat; Medicina personalitzada; Farmacogenòmica, Trastorno por déficit de atención con hiperactividad; Medicina personalizada; Farmacogenómica, Stimulants are the first-line pharmacological treatment for ADHD and generally effective, yet 35–61% of individuals discontinue treatment within a year. We investigated the contribution of common and rare genetic variants to early stimulant discontinuation using data from 18,362 individuals with ADHD (31% female) initiating stimulants in iPSYCH, a Danish population-based case-cohort linked to national registers. Discontinuation was defined as a ≥ 180-day gap between dispensations within one year of initiation. We examined genetic differences by age groups, estimated SNP-heritability (h2SNP), conducted genome-wide association studies (GWAS), polygenic score (PGS) analyses, and assessed associations with protein truncating variants (PTV). Within one year, 7102 individuals (39%) had discontinued stimulants. Age-stratified analyses (cut-off: age 16) revealed low genetic correlation (r₉ = 0.23, 95% CI: –0.37, 0.83) between children and adolescents/adults. The h²snp for discontinuation was 0.06 (95% CI: 0.02, 0.11) overall, 0.08 (95% CI: 0.02, 0.14) in children, and 0.14 (95% CI: 0.02, 0.27) in adolescents/adults. No genome-wide significant loci were identified overall or in adolescents/adults; however, one locus (SLC5A12, chromosome 11) reached genome-wide significance in children. Ten of 36 PGSs were associated with discontinuation, with higher psychiatric risk PGSs predicting increased discontinuation, while educational attainment and BMI PGSs showed divergent effects by age. Reduced burden of dopamine-related PTVs was nominally associated with discontinuation, particularly in adolescents/adults. These findings suggest modest contributions of both common and rare variants to stimulant discontinuation in ADHD and point to potential developmental differences in genetic architecture., This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 965381 (TIMESPAN). This research reflects only the authors’ view, and the European Commission is not responsible for any use that may be made of the information it contains. Ditte Demontis was supported by the Novo Nordisk Foundation (NNF20OC0065561, NNF21SA0072102, NNF23OC0083657), the Lundbeck Foundation (R344-2020-1060). The iPSYCH team was supported by grants from the ISCIII Lundbeck Foundation (R102-A9118, R155-2014-1724, and co-funded R248-2017-2003), NIH/NIMH (1R01MH124851-01 to Anders D. Børglum), and the Universities and University Hospitals of Aarhus and Copenhagen. The Danish National Biobank resource was supported by the Novo Nordisk Foundation. High-performance computer capacity for handling and statistical analysis of iPSYCH data on the GenomeDK HPC facility was provided by the Center for Genomics and Personalized Medicine and the Centre for Integrative Sequencing, iSEQ, Aarhus University, Denmark (grant to Anders D. Børglum). Søren Dalsgaard was supported by Sawmill-owner Jeppe Juhl’s and wife Ovita Juhl’s Fund, The Capital Region (grant No 22042850), and Greater Copenhagen Health Science Partners (CAG Precision Psychiatry, A7763). Marta Soler Artigas acknowledges a Miguel Servet contract (CP22/00128) awarded by the Instituto de Salud Carlos III and co-funded by the European Union Found: Fondo Social Europeo Plus, FSE + . We acknowledge The Swedish Twin Registry for access to data. The Swedish Twin Registry is managed by Karolinska Institutet and receives funding through the Swedish Research Council under the grant no 2021-00180.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Dissecting the polygenic contribution of attention-deficit/hyperactivity disorder and autism spectrum disorder on school performance by their relationship with educational attainment

  • Bosch, Rosa
  • Carabí-Gassol, Pau
  • MACÍAS CHIMBORAZO, VALERIA
  • Español Martin, Gemma
  • Cabana-Dominguez, Judit
  • Soler Artigas, María
  • Alemany, Silvia
  • Llonga, Natalia
  • Vilar-Ribo, Laura
  • Arribas, Lorena
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Attention-deficit/hyperactivity disorder; Autism spectrum disorder; School performance, Trastorn per dèficit d'atenció i hiperactivitat; Trastorn de l'espectre autista; Rendiment escolar, Trastorno por déficit de atención e hiperactividad; Trastorno del espectro autista; Rendimiento escolar, Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD) are strongly associated with educational attainment (EA), but little is known about their genetic relationship with school performance and whether these links are explained, in part, by the genetic liability of EA. Here, we aim to dissect the polygenic contribution of ADHD and ASD to school performance, early manifestation of psychopathology and other psychiatric disorders and related traits by their relationship with EA. To do so, we tested the association of polygenic scores for EA, ADHD and ASD with school performance, assessed whether the contribution of the genetic liability of ADHD and ASD to school performance is influenced by the genetic liability of EA, and evaluated the role of EA in the genetic overlap between ADHD and ASD with early manifestation of psychopathology and other psychiatric disorders and related traits in a sample of 4,278 school-age children. The genetic liability for ADHD and ASD dissected by their relationship with EA show differences in their association with school performance and early manifestation of psychopathology, partly mediated by ADHD and ASD symptoms. Genetic variation with concordant effects in ASD and EA contributes to better school performance, while the genetic variation with discordant effects in ADHD or ASD and EA is associated with poor school performance and higher rates of emotional and behavioral problems. Our results strongly support the usage of the genetic load for EA to dissect the genetic and phenotypic heterogeneity of ADHD and ASD, which could help to fill the gap of knowledge of mechanisms underlying educational outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III (P19/01224, PI20/00041, PI22/00464, PI23/00404, PI23/00026 and FI18/00285 to L.V.R, CP22/00128 to M.S.A and CP22/00026 to S.A), the Network Center for Biomedical Research (CIBER) to J.C.D.; the European Regional Development Fund (ERDF); the ECNP Network ‘ADHD across the Lifespan’; “la Marató de TV3” (202228-30 and 202228-31), “Fundació ‘la Caixa’, Diputació de Barcelona, Pla Estratègic de Recerca i Innovació en Salut” (PERISSLT006/17/285); “Fundació Privada d’Investigació Sant Pau” (FISP); and Ministry of Health of Generalitat de Catalunya.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Genetic architecture of ADHD and overlap with other psychiatric disorders and cognition-related phenotypes

  • hartman, catharina
  • Larsson, Henrik
  • Ribases, Marta
  • Mitjans, Marina
  • Soler Artigas, María
  • Demontis, Ditte
  • Ramos-Quiroga, Josep Antoni
Trastorno por déficit de atención e hiperactividad; Comorbilidad; Genética de trastornos cruzados, Trastorn per dèficit d'atenció i hiperactivitat; Comorbiditat; Genètica de trastorns creuats, Attention-deficit/hyperactivity disorder; Comorbidity; Cross-disorder genetics, Attention-deficit/hyperactivity disorder (ADHD) co-occurs with many other psychiatric disorders and traits. In this review, we summarize and interpret the existing literature on the genetic architecture of these comorbidities based on hypothesis-generating approaches. Quantitative genetic studies indicate that genetic factors play a substantial role in the observed co-occurrence of ADHD with many different disorders and traits. Molecular genetic correlations derived from genome-wide association studies and results of studies based on polygenic risk scores confirm the general pattern but provide effect estimates that are smaller than those from twin studies. The identification of the specific genetic variants and biological pathways underlying co-occurrence using genome-wide approaches is still in its infancy. The first analyses of causal inference using genetic data support causal relationships between ADHD and comorbid disorders, although bidirectional effects identified in some instances point to complex relationships. While several issues in the methodology and inferences from the results are still to be overcome, this review shows that the co-occurrence of ADHD with many psychiatric disorders and traits is genetically interpretable., This research has received funding from the EU’s Horizon 2020 research and innovation program under grant agreements no. 667302 (CoCA), 728018 (Eat2beNICE) and 2020604 (TIMESPAN) and from the ECNP Network ‘ADHD across the Lifespan' (https://www.ecnp.eu/researchinnovation/ECNP-networks/List-ECNP-Networks/). B Cormand has also been supported by the Spanish Ministerio de Ciencia, Innovación y Universidades (PID2021-1277760B-I100), the Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas (PNSD-2017I050), Fundació La Marató de TV3 (202218-31), Generalitat de Catalunya/AGAUR (2021-SGR-1093), ICREA Academia 2021 and the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 841899 (GRASAD) and 101028810 (ATTENTIVE). M Ribasés was also supported by the European Union H2020 Programme (H2020/2014–2020) under grant agreement no. 848228 (DISCOvERIE), by the Instituto de Salud Carlos III (PI20/00041, CP09/00119 and CPII15/00023), by the Pla estratègic de recerca i innovació en salut (PERIS), Generalitat de Catalunya (METAL-Cat; SLT006/17/287), by the Agència de Gestió d'Ajuts Universitaris i de Recerca AGAUR, Generalitat de Catalunya (2017SGR1461) and by Fundació La Marató de TV3 (202228-30, 202228-31). JA Ramos-Quiroga was also supported by the European Union H2020 Programme (H2020/2014–2020) under grant agreement no. 848228 (DISCOvERIE). M Mitjans was supported by Horizon 2020 Marie Sklodowska-Curie Individual Fellowship from the European Commission under grant agreement no. 841899 (GRASAD), the MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU”/PRTR” (RYC2021-033573-I), Ministerio de Ciencia e Innovación (PID2022-139740OA-100) and the Agència de Gestió d'Ajuts Universitaris i de Recerca AGAUR, Generalitat de Catalunya (2021-SGR-1093). M Soler Artigas was supported by the Instituto de Salud Carlos III (P19/01224, PI22/00464 and CP22/00128) and by the European Regional Development Fund. B Franke and A Reif were also supported by funding from the EU’s Horizon 2020 research and innovation program under grant agreement no. 847879 (PRIME). B Franke also received relevant funding from the Netherlands Organization for Scientific Research (NWO) for the GUTS project (grant 024.005.011). D Demontis is supported by the Novo Nordisk Foundation (NNF20OC0065561 and NNF21SA0072102), the Lundbeck Foundation (R344-2020-1060), the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 965381 (TIMESPAN). AD Børglum was supported by the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003). Research reported in this publication was also supported by the National Institute of Mental Health of the National Institutes of Health under Award Number R01MH124851. The content of the publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or any of the other funding organisations mentioned here.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Transcriptomic risk scores for attention deficit/hyperactivity disorder

  • Arribas, Lorena
  • Demontis, Ditte
  • Cabana-Dominguez, Judit
  • Llonga, Natalia
  • Alemany, Silvia
  • Vilar-Ribo, Laura
  • Fadeuilhe, Christian
  • Corrales, Montserrat
  • Richarte, Vanesa
  • Soler Artigas, María
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Transcriptomic risk scores; Attention deficit and hyperactivity disorder, Puntuaciones de riesgo transcriptómico; Trastorno por déficit de atención e hiperactividad, Puntuació de risc transcriptòmic; Trastorn per dèficit d'atenció i hiperactivitat, Attention deficit/hyperactivity disorder (ADHD) is a highly heritable neurodevelopmental disorder. We performed a transcriptome-wide association study (TWAS) using the latest genome-wide association study (GWAS) meta-analysis, in 38,691 individuals with ADHD and 186,843 controls, and 14 gene-expression reference panels across multiple brain tissues and whole blood. Based on TWAS results, we selected subsets of genes and constructed transcriptomic risk scores (TRSs) for the disorder in peripheral blood mononuclear cells of individuals with ADHD and controls. We found evidence of association between ADHD and TRSs constructed using expression profiles from multiple brain areas, with individuals with ADHD carrying a higher burden of TRSs than controls. TRSs were uncorrelated with the polygenic risk score (PRS) for ADHD and, in combination with PRS, improved significantly the proportion of variance explained over the PRS-only model. These results support the complementary predictive potential of genetic and transcriptomic profiles in blood and underscore the potential utility of gene expression for risk prediction and deeper insight in molecular mechanisms underlying ADHD., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-1461, 2021SGR-00840), the Instituto de Salud Carlos III and co-funded by the European Union Found: Fondo Social Europeo Plus (FSE+) (P19/01224, PI20/00041, PI22/00464 and FI18/00285 to LVR, CP22/00128 to MSA and CP22/00026 to SA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD), the Network Center for Biomedical Research (CIBER) to JCD, the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014-2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN), the ECNP Network ‘ADHD across the Lifespan’ and the “la Marató de TV3” (202228-30 and 202228-31). ADB was supported by grants from the Lundbeck Foundation (R102-A9118, R155-2014-1724, and R248-2017-2003) and NIH/NIMH (1R01MH124851-01). DD was supported by the Novo Nordisk Foundation (NNF20OC0065561) and the Lundbeck Foundation (R344-2020-1060).